Prognosis and characteristics of renal cell carcinoma in hemodialysis patients: Bilateral occurrence does not influence cancer-specific survival

International Journal of Urology

Volumn 18, Issue 12, 2011, Pages 806-812

  Takagi, Toshio ^a   Kondo, Tsunenori ^a   Izuka, Jyunpei ^a   Kobayashi, Hirohito ^a   Tomita, Eri ^a   Hashimoto, Yasunobu ^a   Tanabe, Kazunari ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

End stage kidney disease; Hemodialysis; Nephrectomy; Renal cell carcinoma; Survival

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER SIZE; CANCER SURVIVAL; CLEAR CELL CARCINOMA; FEMALE; FOLLOW UP; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; KIDNEY CARCINOMA; KIDNEY FAILURE; KIDNEY POLYCYSTIC DISEASE; MAJOR CLINICAL STUDY; MALE; MULTIPLE CANCER; NEPHRECTOMY; PAPILLARY CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; TREATMENT DURATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY DISEASES, CYSTIC; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASMS, MULTIPLE PRIMARY; NEOPLASMS, SECOND PRIMARY; NEPHRECTOMY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RENAL DIALYSIS; TIME FACTORS; TUMOR BURDEN; YOUNG ADULT;

EID: 83055194314     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2011.02852.x     Document Type: Article

References (25)

1. Ishikawa I. Re: acquired cystic disease of the kidney: a management dilemma. J. Urol. 1993; 149: 1146-8.
2. Hori Y, Oda Y, Kiyoshima K etal. Oxidative stress and DNA hypermethylation status in renal cell carcinoma arising in patients on dialysis. J. Pathol. 2007; 212: 218-26.
3. Yoshimura S, Suemizu H, Nomoto Y etal. Plasma glutathione peroxidase deficiency caused by renal dysfunction. Nephron 1996; 73: 207-11.
4. Maisonneuve P, Agodoa L, Gellert R etal. Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet 1999; 354: 93-9.
5. Haferkamp A, Kurosch M, Pritsch M etal. Prognostic factors influencing long-term survival of patients undergoing nephron-sparing surgery for nonmetastatic renal-cell carcinoma (RCC) with imperative indications. Ann. Surg. Oncol. 2009; 17: 544-51.
6. Amano H, Kondo T, Hashimoto Y etal. Contralateral metachronous tumor occurrence is more frequently associated with distant metastases or postoperative intrarenal recurrence in renal cell carcinoma patients. Int. J. Urol. 2010; 17: 615-22.
7. Neuzillet Y, Tillou X, Mathieu R etal. Renal cell carcinoma (RCC) in patients with end-stage renal disease exhibits many favourable clinical, pathologic, and outcome features compared with RCC in the general population. Eur. Urol. 2011; 60: 366-73.
8. Sassa N, Hattori R, Tsuzuki T etal. Renal cell carcinomas in haemodialysis patients: does haemodialysis duration influence pathological cell types and prognosis? Nephrol. Dial. Transplant. 2011; 26: 1677-82.
9. Siemer S, Uder M, Zell A etal. [Bilateral kidney tumor. Therapy management and histopathological results with long-term follow-up of 66 patients]. Urologe A 2001; 40: 114-20. (In German).
10. Zincke H, Swanson SK. Bilateral renal cell carcinoma: influence of synchronous and asynchronous occurrence on patient survival. J. Urol. 1982; 128: 913-15.
11. Ishikawa I. Uremic acquired renal cystic disease. Natural history and complications. Nephron 1991; 58: 257-67.
12. Grantham JJ, Levine E. Acquired cystic disease: replacing one kidney disease with another. Kidney Int. 1985; 28: 99-105.
13. Boorjian SA, Crispen PL, Lohse CM, Leibovich BC, Blute ML. The impact of temporal presentation on clinical and pathological outcomes for patients with sporadic bilateral renal masses. Eur. Urol. 2008; 54: 855-63.
14. Klatte T, Wunderlich H, Patard JJ etal. Clinicopathological features and prognosis of synchronous bilateral renal cell carcinoma: an international multicentre experience. BJU Int. 2007; 100: 21-5.
15. Denton MD, Magee CC, Ovuworie C etal. Prevalence of renal cell carcinoma in patients with ESRD pre-transplantation: a pathologic analysis. Kidney Int. 2002; 61: 2201-9.
16. Hughson MD, Bigler S, Dickman K, Kovacs G. Renal cell carcinoma of end-stage renal disease: an analysis of chromosome 3, 7, and 17 abnormalities by microsatellite amplification. Mod. Pathol. 1999; 12: 301-9.
17. Kojima Y, Takahara S, Miyake O, Nonomura N, Morimoto A, Mori H. Renal cell carcinoma in dialysis patients: a single center experience. Int. J. Urol. 2006; 13: 1045-8.
18. Boileau M, Foley R, Flechner S, Weinman E. Renal adenocarcinoma and end stage kidney disease. J. Urol. 1987; 138: 603-6.
19. Satoh S, Tsuchiya N, Habuchi T, Ishiyama T, Seimo K, Kato T. Renal cell and transitional cell carcinoma in a Japanese population undergoing maintenance dialysis. J. Urol. 2005; 174: 1749-53.
20. Blute ML, Itano NB, Cheville JC, Weaver AL, Lohse CM, Zincke H. The effect of bilaterality, pathological features and surgical outcome in nonhereditary renal cell carcinoma. J. Urol. 2003; 169: 1276-81.
21. Bani-Hani AH, Leibovich BC, Lohse CM, Cheville JC, Zincke H, Blute ML. Associations with contralateral recurrence following nephrectomy for renal cell carcinoma using a cohort of 2, 352 patients. J. Urol. 2005; 173: 391-4.
22. Hughson MD, Schmidt L, Zbar B etal. Renal cell carcinoma of end-stage renal disease: a histopathologic and molecular genetic study. J. Am. Soc. Nephrol. 1996; 7: 2461-8.
23. Ishikawa I, Kovacs G. High incidence of papillary renal cell tumours in patients on chronic haemodialysis. Histopathology 1993; 22: 135-9.
24. Amin MB, Amin MB, Tamboli P etal. Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases. Am. J. Surg. Pathol. 2002; 26: 281-91.
25. Tickoo SK, dePeralta-Venturina MN, Harik LR etal. Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia. Am. J. Surg. Pathol. 2006; 30: 141-53.